KRMD KORU Medical Systems, Inc. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$4.03

Period return

-1.65 (-29.05%)

Volume

198.5K

2026-07-21O $4.04 H $4.22 L $3.98 C $4.03MA5 $4.11MA20 $4.29MA60 $4.11MA120 $4.34

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 08. 05.Highin 15 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 15.High2 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.00%
2026. 03. 14.LowBUY4 months ago
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2026. 03. 14.LowBUY4 months ago
B. Riley Securities: Buy
US analyst rating / recommendation change.
2025. 12. 23.LowBUY7 months ago
Lake Street: Buy
US analyst rating / recommendation change.
2025. 12. 18.LowBUY7 months ago
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2025. 08. 07.LowHOLD12 months ago
Piper Sandler: Neutral
US analyst rating / recommendation change.
2025. 05. 09.LowHOLDlast year
Piper Sandler: Neutral
US analyst rating / recommendation change.
2025. 03. 31.Mediumlast year
2026년 1분기 실적 발표
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 02. 14.MediumHOLDlast year
Piper Sandler: Neutral
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $6.8 · 5 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Sector: Healthcare
Industry: Medical Instruments & Supplies
HQ: Mahwah, NJ, United States
Fiscal year end: —
Employees: 73
IPO date: —

View details →

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 05.	After market close (AMC)	$-0.01	—	—	$11.62M	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$-0.03	—	—	$9.64M	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$0.1	—	—	$24.81M	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$0.06	—	—	$16.63M	Reported

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	91,645	$395.91K	0.00%	—	New position
2	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	30,643	$178.04K	0.00%	—	New position

KORU Medical Systems, Inc.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 03. 14.	Canaccord Genuity	—	Maintain	Buy → Buy	—	Canaccord Genuity: Buy
2026. 03. 14.	B. Riley Securities	—	Maintain	Buy → Buy	—	B. Riley Securities: Buy
2025. 12. 23.	Lake Street	—	Maintain	Buy → Buy	—	Lake Street: Buy
2025. 12. 18.	Canaccord Genuity	—	Maintain	Buy → Buy	—	Canaccord Genuity: Buy
2025. 08. 07.	Piper Sandler	—	Maintain	Neutral → Neutral	—	Piper Sandler: Neutral
2025. 05. 09.	Piper Sandler	—	Maintain	Neutral → Neutral	—	Piper Sandler: Neutral